Morgan Stanley Zimmer Biomet Holdings, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,048,837 shares of ZBH stock, worth $226 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,048,837

Previous 2,409,594 14.97%

Holding current value

$226 Million

Previous $262 Million 15.43%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$104.47 - $116.17 $37.7 Million - $41.9 Million	-360,757 Reduced 14.97%	2,048,837 $221 Million
Q2 2024 Oct 17, 2024	BUY	$106.25 - $130.01 $20 Million - $24.5 Million	188,617 Added 8.49%	2,409,594 $262 Million
Q2 2024 Aug 14, 2024	BUY	$106.25 - $130.01 $20 Million - $24.5 Million	188,617 Added 8.49%	2,409,594 $262 Million
Q1 2024 Oct 17, 2024	SELL	$119.98 - $132.61 $22.6 Million - $25 Million	-188,617 Reduced 7.83%	2,220,977 $293 Million
Q1 2024 Aug 16, 2024	SELL	$119.98 - $132.61 $67.1 Million - $74.1 Million	-559,108 Reduced 20.11%	2,220,977 $293 Million
Q1 2024 May 15, 2024	SELL	$119.98 - $132.61 $67.1 Million - $74.1 Million	-559,108 Reduced 20.11%	2,220,977 $293 Million
Q4 2023 Aug 16, 2024	BUY	$102.72 - $121.7 $38.1 Million - $45.1 Million	370,491 Added 15.38%	2,780,085 $338 Million
Q4 2023 Feb 13, 2024	BUY	$102.72 - $121.7 $31 Million - $36.7 Million	301,394 Added 12.16%	2,780,085 $338 Million
Q3 2023 Nov 15, 2023	SELL	$110.76 - $143.18 $89.5 Million - $116 Million	-807,806 Reduced 24.58%	2,478,691 $278 Million
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $595,358 - $685,630	4,709 Added 0.14%	3,286,497 $479 Million
Q1 2023 May 15, 2023	BUY	$121.91 - $130.94 $21.9 Million - $23.5 Million	179,359 Added 5.78%	3,281,788 $424 Million
Q4 2022 Feb 14, 2023	BUY	$104.7 - $128.4 $145 Million - $178 Million	1,384,068 Added 80.55%	3,102,429 $396 Million
Q3 2022 Nov 14, 2022	SELL	$101.65 - $119.27 $530,206 - $622,112	-5,216 Reduced 0.3%	1,718,361 $180 Million
Q2 2022 Oct 27, 2022	BUY	$102.23 - $133.85 $93.9 Million - $123 Million	918,447 Added 114.07%	1,723,577 $181 Million
Q2 2022 Aug 15, 2022	BUY	$102.23 - $133.85 $93.9 Million - $123 Million	918,447 Added 114.07%	1,723,577 $181 Million
Q1 2022 Oct 27, 2022	SELL	$108.42 - $129.58 $99.6 Million - $119 Million	-918,447 Reduced 53.29%	805,130 $103 Million
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $22.7 Million - $27.1 Million	-209,395 Reduced 20.64%	805,130 $103 Million
Q4 2021 Feb 14, 2022	BUY	$115.43 - $146.63 $10.2 Million - $13 Million	88,703 Added 9.58%	1,014,525 $129 Million
Q3 2021 Nov 15, 2021	BUY	$136.35 - $158.76 $126 Million - $147 Million	925,822 New	925,822 $136 Million

Others Institutions Holding ZBH

# of Institutions

1,080

Shares Held

179M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account